Skip to main content Skip to section navigation Skip to footer
About
Our Science
Therapeutic Areas Platform Partnering
Pipeline Careers Media & Resources Investors Contact
Contact

Press Releases

Investors

Investors

  • Overview
  • Company Info
    • Executive Team
    • Presentations
    • Contacts
    • FAQ
  • News & Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Financials
  • Stock Data
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Current Reports
  • Annual Shareholder Reports
  • Corporate Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Press Releases
  • IR Calendar
  • Email Alerts
Dec 23, 2019 8:30 am EST
iBio Announces Collaboration with EdgePoint AI for Next Gen Quality in Biologics Manufacturing
Dec 16, 2019 4:15 pm EST
iBio Reports Progress on its Bio-Better Rituximab Collaboration with CC-Pharming
Dec 13, 2019 5:00 pm EST
iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan
Dec 10, 2019 4:44 pm EST
iBio Introduces FastGlycaneering Development Service™ to Power Recombinant Protein Production
Dec 3, 2019 12:31 pm EST
iBio Joins Manufacturing USA’s Tissue Biofabrication Initiative
Dec 2, 2019 4:15 pm EST
iBio to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference
Oct 25, 2019 8:30 am EDT
iBio, Inc. Prices $5,000,000 Public Offering
Oct 22, 2019 4:30 pm EDT
iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan
Sep 17, 2019 4:15 pm EDT
iBio’s Collaboration with South Africa’s AzarGen Biotechnologies Advances to Next Stage
Aug 26, 2019 5:30 pm EDT
iBio and CC-Pharming Expand Business Collaboration in China
  • Page 1
  • Page 2
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
Therapeutic Areas Pipeline Platform Partnering
About Careers Media & Events Investors
Contact

11750 Sorrento Valley Road
Suite 200
San Diego, CA 92121

(979) 446-0027 → info@ibioinc.com → LinkedIn →
Privacy Policy and Terms of Use

©2026 iBio, Inc. All rights reserved.